Navigating Status Epilepticus: Breakthroughs in Management

In this episode, we delve into the complexities of managing status epilepticus, particularly the refractory stages that resist initial treatments. Status epilepticus is a neurological emergency that requires prompt medical intervention to prevent significant morbidity and mortality. Despite aggressive treatment, some cases do not respond to initial lines of therapy. Refractory and super refractory status epilepticus pose significant treatment challenges and carry high risks, including neuronal injury, long-term neurological deficits, and increased mortality.  Tune in to learn more about the approaches to refractory and super refractory status epilepticus management, novel strategies that are gaining traction, unique considerations in the pediatric population, and new research looking at biomarkers in new-onset refractory status epilepticus (NORSE) to predict short- and long-term outcomes. With Clio Rubinos, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Maria Roberta Cilio, MD, PhD, Université Catholique de Louvain, Brussels, Belgium; and Aurelie Hanin, PharmD, PhD, Yale University, New Haven, CT.